創立于1999年,主打諾迪康膠囊及十味蒂達膠囊,集藏藥/植物藥/化學藥/生物制品等的研制銷售為一體的制藥企業
西藏諾迪康藥(yao)業股份有限(xian)公司于(yu)1999年7月14日在西藏自治區創立(li),1999年7月21日在上(shang)海證券交易所上(shang)網交易,是一家(jia)高新(xin)技術制藥(yao)上(shang)市企業,股票名稱(cheng):西藏藥(yao)業,股票代碼:600211。
公司秉承“科學成(cheng)就健康,健康成(cheng)就未來”的(de)(de)(de)理念,以科技興(xing)業(ye)。在為藏藥(yao)現代化(hua)不遺余力的(de)(de)(de)同時,注巨資于生物制(zhi)品(pin)和傳統藥(yao)品(pin)的(de)(de)(de)研發(fa),經過多年來的(de)(de)(de)不懈努力,西(xi)藏藥(yao)業(ye)已建成(cheng)一個(ge)(ge)國家級(ji)企業(ye)技術(shu)中心、三個(ge)(ge)符(fu)合(he)GMP規范的(de)(de)(de)藥(yao)品(pin)生產(chan)基(ji)地(di)、一個(ge)(ge)符(fu)合(he)GAP規范的(de)(de)(de)藏藥(yao)材種植基(ji)地(di),產(chan)品(pin)涵蓋生物制(zhi)品(pin)、藏藥(yao)、中藥(yao)和化(hua)學藥(yao)領(ling)域,銷(xiao)售網絡遍及(ji)全國各省、自治區、直轄(xia)市,依(yi)姆多的(de)(de)(de)銷(xiao)售網絡更是遍及(ji)全球約40個(ge)(ge)國家和地(di)區。
截止2019年(nian)12月31日,公(gong)(gong)(gong)(gong)(gong)司(si)現(xian)有(you)在職員工500余(yu)人,總資產27.67億(yi)元(yuan),實現(xian)年(nian)營業收入12.56億(yi)元(yuan)。擁有(you)西藏(zang)諾(nuo)(nuo)迪(di)康(kang)醫藥(yao)(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、成(cheng)都諾(nuo)(nuo)迪(di)康(kang)生物制藥(yao)(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、四川(chuan)諾(nuo)(nuo)迪(di)康(kang)威(wei)光制藥(yao)(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、西藏(zang)諾(nuo)(nuo)迪(di)康(kang)藏(zang)藥(yao)(yao)(yao)材開(kai)發(fa)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、香港拓(tuo)普瑞(rui)吉藥(yao)(yao)(yao)業有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)、西藏(zang)諾(nuo)(nuo)迪(di)康(kang)農業資源開(kai)發(fa)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)和西藏(zang)氧道大(da)健康(kang)生命科(ke)學(xue)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)等下(xia)屬子公(gong)(gong)(gong)(gong)(gong)司(si)。